v3.24.1.u1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Common Stock
Follow on Offering
Additional Paid-In Capital
Other Accumulated Comprehensive Gain (loss)
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022     82,385,810        
Beginning Balance at Dec. 31, 2022   $ 0 $ 82   $ 1,767,266 $ (374) $ (1,754,374)
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2022   0          
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2023   0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock in connection with follow-on offering (in shares)       0      
Issuance of common stock in connection with follow-on offering       $ 0      
Issuance of common stock in connection with follow-on offering, net of underwriting discounts and offering costs         0    
Issuance of common stock related to stock awards, net of cancellation (in shares)     1,188,248        
Issuance of common stock related to stock awards, net of cancellation     $ 1   (1)    
Issuance of common stock upon exercise of stock options (in shares)     562,039        
Issuance of common stock upon exercise of stock options     $ 1   9,481    
Shares withheld related to net settlement of restricted stock awards (in shares)     (118,889)        
Shares withheld related to net settlement of stock awards         (3,730)    
Stock-based compensation         14,489    
Other         30    
Unrealized gain (loss) $ 249         249  
Net loss $ (59,793)           (59,793)
Ending Balance (in shares) at Mar. 31, 2023 84,017,208   84,017,208        
Ending Balance at Mar. 31, 2023 $ (26,673) $ 0 $ 84   1,787,535 (125) (1,814,167)
Beginning Balance (in shares) at Dec. 31, 2022     82,385,810        
Beginning Balance at Dec. 31, 2022   $ 0 $ 82   1,767,266 (374) (1,754,374)
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2022   0          
Preferred Stock, Ending Balance (in shares) at Dec. 31, 2023 0 0          
Ending Balance (in shares) at Dec. 31, 2023 87,962,765   87,962,765        
Ending Balance at Dec. 31, 2023 $ (151,604) $ 0 $ 88   1,926,654 14 (2,078,360)
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2024 0 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock in connection with follow-on offering (in shares)       16,000,000      
Issuance of common stock in connection with follow-on offering       $ 16      
Issuance of common stock in connection with follow-on offering, net of underwriting discounts and offering costs         97,110    
Issuance of common stock related to stock awards, net of cancellation (in shares)     497,844        
Issuance of common stock related to stock awards, net of cancellation         0    
Issuance of common stock upon exercise of stock options (in shares)     7,722        
Issuance of common stock upon exercise of stock options     $ 0   20    
Shares withheld related to net settlement of restricted stock awards (in shares)     (58,533)        
Shares withheld related to net settlement of stock awards     $ 0   (402)    
Stock-based compensation         9,378    
Other         0    
Unrealized gain (loss) $ (39)         (39)  
Net loss $ (53,152)           (53,152)
Ending Balance (in shares) at Mar. 31, 2024 104,409,798   104,409,798        
Ending Balance at Mar. 31, 2024 $ (98,673) $ 0 $ 104   $ 2,032,760 $ (25) $ (2,131,512)